Core-004
Core-004
批准号:
10198073
负责人:
David H Ellison
金额:
$70.08万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-02 至 2022-08-30
关键词:
AchievementAreaBiometryClinical ResearchComplexConsultationsData AnalysesDevelopmentEnsureFosteringFundingGoalsHealthInfrastructureInstitutionInterventionKnowledgeMeasuresMethodologyMissionOregonProcessReportingResearch DesignResearch EthicsResearch InstituteResearch MethodologyResource SharingServicesSystemTimeTrainingTranslatingTranslational ResearchUniversitiesdesignepidemiology studyexperienceflexibilityhuman subject protectionimprovedinnovationprogramssuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Research Methods section comprises two components focused on planning, operationalizing, and
implementing high quality Clinical and Translational Research (CTR) at OHSU and partnering institutions:
Biostatistics, Epidemiology and Research Design (BERD), and Regulatory Knowledge and support (RKS). In
OCTRI 2.0, each of these components has well-articulated goals, accompanied by relevant specific aims to
accomplish those goals. All the Research Methods aims are well aligned with the overarching aims for OCTRI;
contributions for each of the modules toward achievement of those aims will be measured and evaluated. Both
components capitalize on achievements in the prior OCTRI funding cycles, and leverage activities of
successful units that are essential to the OHSU infrastructure (in particular the Biostatistics & Design Program
[BDP] and the Office of Clinical Research), to ensure efficient and timely progress toward goals.
In recent years, great strides have been made tackling CTR challenges; however, the studies of complex
systems requires innovative methodologies and processes to effectively and efficiently translate discoveries
into interventions to improve health. Indispensable to the success of CTR are considerations in the areas of
research ethics, study design, data analyses, and interpretation. Thus, Cores dedicated to planning,
operationalizing, and implementing high quality CTR at OHSU are essential for achieving the overarching
goals of OCTRI 2.0. Responding to the challenges put forth in the IOM report to drive innovation in CTR,
OCTRI’s Biostatistics, Epidemiology and Research Design component (OCTRI-BERD) proposes initiatives
aimed at fostering methodology development, providing flexible personalized training experiences, and
promoting professional development of BERD practitioners. In addition, OCTRI-BERD will further enhance the
provision of collaborative and consultative services offered through our Biostatistics University Shared
Resource, Biostatistics & Design Program. The Regulatory Knowledge and Support component proposes
initiatives aimed at delivery of regulatory consultations services, training the workforce in human subjects’
protections, and alleviating regulatory-related bottlenecks in CTR. These efforts will further OCTRI’s missions
and catalyze CTR regionally and throughout the CTSA network.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core-003
-
批准号:10198072
-
项目类别:
-
资助金额:$93.68万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Admin-Core-001
-
批准号:10198069
-
项目类别:
-
资助金额:$90.49万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute Quality Assurance and Quality Control Project
-
批准号:10158949
-
项目类别:
-
资助金额:$14.93万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:10198068
-
项目类别:
-
资助金额:$630.8万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:10693308
-
项目类别:
-
资助金额:$967.3万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-005
-
批准号:10198074
-
项目类别:
-
资助金额:$164.5万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:9514362
-
项目类别:
-
资助金额:$616.99万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)
-
批准号:10179888
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-001
-
批准号:10198070
-
项目类别:
-
资助金额:$68.71万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-002
-
批准号:10198071
-
项目类别:
-
资助金额:$41.36万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute - Evaluation of OCTRI's Response to COVID-19
-
批准号:10158990
-
项目类别:
-
资助金额:$9.35万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-007
-
批准号:10198076
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-006
-
批准号:10198075
-
项目类别:
-
资助金额:$65.22万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:10675189
-
项目类别:
-
资助金额:$967.3万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:9977301
-
项目类别:
-
资助金额:$633.75万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:9816556
-
项目类别:
-
资助金额:$17.88万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Renal Effects of Aldosterone
-
批准号:10266000
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:David H Ellison
-
依托单位:
Renal and extrarenal toxicity of aldosterone
-
批准号:9280815
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:David H Ellison
-
依托单位:
Renal and extrarenal toxicity of aldosterone
-
批准号:8635009
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:David H Ellison
-
依托单位:
Molecular pathogenesis of calcineurin inhibitor-induced hypertension
-
批准号:8549218
-
项目类别:
-
资助金额:$35.68万
-
财政年份:2012
-
负责人:David H Ellison
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: